Katie Covington, PA
Medical · Woodstock, GANPI 1407893217
Payments from drug & device makers
Across 265 payments — averaging $19.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$928
- LEO Pharma Inc.$809
- Regeneron Healthcare Solutions, Inc.$446
- Sanofi$365
- Dermavant Sciences, Inc.$296
- Incyte Corporation$282
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,89596%
- Education$1804%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $928 |
| LEO Pharma Inc. | 39 | $809 |
| Regeneron Healthcare Solutions, Inc. | 13 | $446 |
| Sanofi | 13 | $365 |
| Dermavant Sciences, Inc. | 14 | $296 |
| Incyte Corporation | 16 | $282 |
| Arcutis Biotherapeutics, Inc. | 20 | $268 |
| Johnson & Johnson | 15 | $252 |
| Galderma Laboratories, L.p. | 15 | $251 |
| Novartis | 11 | $222 |
| Pfizer | 8 | $172 |
| Botanix SB Inc | 8 | $143 |
| Amgen | 5 | $95 |
| Lilly USA, LLC | 4 | $80 |
| Sun Pharmaceutical Industries Inc. | 5 | $77 |
| Organon | 4 | $75 |
| UCB, Inc. | 3 | $56 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Almirall LLC | 2 | $37 |
| Medtronic | 2 | $33 |
| EPI Health, LLC | 2 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Revance Therapeutics, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $16 |
| Mayne Pharma Commercial LLC | 1 | $15 |
How this compares
$5,075 in reported general payments places this provider in the 80th percentile of 950 medical providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $63,553 |
| Clobetasol Propionate | 53 | $2,062 |
| Metronidazole | 19 | $942 |
| Ketoconazole | 73 | $910 |
| Fluocinonide | 23 | $570 |
| Doxycycline Hyclate | 29 | $467 |
| Triamcinolone Acetonide | 38 | $384 |
| Fluticasone Propionate | 19 | $306 |
| Hydrocortisone | 22 | $90 |
| Mupirocin | 15 | $77 |
| Minoxidil | 18 | $62 |
Paid to pharmacies, not to this prescriber.
Other medical in Woodstock
- Tomas ChaoWoodstock$1.9M
- Nicole RiveraWoodstock$10K
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Felicia HoffmanRoswell$114K
- Sally BrumbillLithia Springs$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.